REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 32 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,000 | – | 1,000 | -66.7% | 0.00% | – |
| Q4 2016 | $0 | – | 3,000 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 3,000 | -71.4% | 0.00% | – |
| Q1 2016 | $3,000 | 0.0% | 10,500 | +23.5% | 0.00% | – |
| Q4 2015 | $3,000 | -70.0% | 8,500 | -54.1% | 0.00% | – |
| Q3 2015 | $10,000 | -16.7% | 18,500 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | -14.3% | 18,500 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | +16.7% | 18,500 | +5.7% | 0.00% | – |
| Q4 2014 | $12,000 | -14.3% | 17,500 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | -6.7% | 17,500 | 0.0% | 0.00% | – |
| Q2 2014 | $15,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $130,000 | 0.07% |
| Benin Management CORP | 83,000 | $72,000 | 0.04% |
| CONDOR CAPITAL MANAGEMENT | 114,987 | $100,000 | 0.03% |
| FIRST NEW YORK SECURITIES LLC /NY | 15,000 | $13,050,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $19,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $157,000 | 0.00% |
| Moors & Cabot, Inc. | 25,000 | $22,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,566 | $4,000 | 0.00% |
| AQR Capital Management | 213,900 | $186,000 | 0.00% |